A UCSF-developed program that integrates behavioral health support for children and caregivers into routine pediatric care is poised to expand across California.
A UCSF team engineered immune cells to activate exclusively in the brain and attack diffuse midline glioma. It worked in mice and it’s poised for a clinical trial at UCSF. A UCSF team developed a CAR T-cell therapy called "B-SYNC" that handily beats the deadly brain cancer, diffuse…
Vikaas Sohal, Alex Marson, and Melanie Ott are elected to the Academy, and Claire Brindis and Kristine Yaffe are honored for their achievements in mental health and health policy. Vikaas Sohal, Melanie Ott, and Alex Marson have been elected to the National Academy of Medicine. Kristine Yaffe and…
UCSF has been selected by the Centers for Disease Control (CDC) to establish a national center focused on improving the early detection and management of dementia, housed in the School of Nursing.
A new AI-based model can predict where the most common malignant brain cancer is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.
Gerdts, Kashem, Pownall, and Zaro receive five years of federal funding for high-risk, high-reward research. Four UCSF faculty members will each receive over $2 million in total over the next five years as members of the 2026 class of New Innovators in the Common Fund’s High-Risk, High-Reward…
UCSF scientists identified how proteins in the blood are linked to a shift in brain aging decades later. A new study looks at how blood signatures in menopausal women predict their dementia risk.
Preliminary study shows symptoms of depression and anxiety improved after switching to a healthier diet. A UCSF study that found people with serious depression had significantly improved symptoms when they switched to a diet consisting of less utlra-processed food.
UCSF-led team proposes a new way to put psychedelic drugs to a more rigorous scientific test. UCSF researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing control treatments to better measure the drugs' true…
UCSF and UC Berkeley scientists pinpointed two brain regions that battle it out when deciding whether to take a risk. How does your brain decide whether to hit “send” on a risky email or delete the draft? Two neighboring parts of it argue with each other until one overrules the other. Researchers…
